| Issuer / Guarantor | Halozyme Therapeutics Inc |
|---|---|
| Size | USD 1050mn |
| Type | Convertible |
| Leads | BoA, Evercore |
| Maturity | 01 Oct 2033 (7 years) |
| Coupon | 1.125 - 1.625% |
| Premium | 27.5% |
| Calls | NC4; PC @ 130% w table MW |
| Puts | t/o @ 100% |
| Div protection | Ratio adjustment (Full) |
| T/o protection | Make-whole table |
| CoCo | 130% to Mar 2033 (6.5 yrs) |
| Announced | 16 Sep 2026 |